APA (7th ed.) Citation

Knöchel, J., Bergenholm, L., Ibrahim, E., Kechagias, S., Hansson, S., Liljeblad, M., . . . Ueckert, S. (2023). A Markov model of fibrosis development in nonalcoholic fatty liver disease predicts fibrosis progression in clinical cohorts. CPT: Pharmacometrics & Systems Pharmacology, 12(12), 2038. https://doi.org/10.1002/psp4.13052

Chicago Style (17th ed.) Citation

Knöchel, Jane, et al. "A Markov Model of Fibrosis Development in Nonalcoholic Fatty Liver Disease Predicts Fibrosis Progression in Clinical Cohorts." CPT: Pharmacometrics & Systems Pharmacology 12, no. 12 (2023): 2038. https://doi.org/10.1002/psp4.13052.

MLA (9th ed.) Citation

Knöchel, Jane, et al. "A Markov Model of Fibrosis Development in Nonalcoholic Fatty Liver Disease Predicts Fibrosis Progression in Clinical Cohorts." CPT: Pharmacometrics & Systems Pharmacology, vol. 12, no. 12, 2023, p. 2038, https://doi.org/10.1002/psp4.13052.